FDA CDC News6 months ago
FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder
The U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT)...